Approximately 2.6 million adults in Great Britain were using weight-loss medications by August, reflecting an increase of roughly 700,000 individuals since February. Research conducted by Worldpanel by Numerator indicates that at least one resident consumes these treatments in 8.5% of domestic properties across the region.

The growing consumption is driven by the introduction of approved pill formulations and an increase in male participants. Consequently, households featuring occupants on GLP-1 medications now outnumber those adhering to vegetarian and pescatarian diets combined.

Additional information regarding these pharmaceutical trends is anticipated as further findings emerge.